0
Xenetic Biosciences, Inc. Banner Image

Xenetic Biosciences, Inc.

  • Ticker XBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Xenetic Biosciences, Inc. Logo Image
  • 1-10 Employees
  • Based in Framingham, Massachusetts
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCARTâ„¢, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomasMore. XCARTâ„¢ has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
REPORT RATINGS
4.8 / 5.0 (232)

Xenetic Biosciences, Inc. reports have an aggregate usefulness score of 4.8 based on 232 reviews.

Xenetic Biosciences, Inc.

Most Recent Annual Report

Xenetic Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Xenetic Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!